Skip Navigation


IJE Advance Access originally published online on June 19, 2009
International Journal of Epidemiology 2009 38(4):971-975; doi:10.1093/ije/dyp162
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/4/971    most recent
dyp162v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brennan, P.
Right arrow Articles by Smith, G. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brennan, P.
Right arrow Articles by Smith, G. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2009; all rights reserved.

Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype

Paul Brennan1,*, James McKay1, Lee Moore2, David Zaridze3, Anush Mukeria3, Neonilia Szeszenia-Dabrowska4, Jolanta Lissowska5, Peter Rudnai6, Eleonora Fabianova7, Dana Mates8, Vladimir Bencko9, Lenka Foretova10, Vladimir Janout11, Wong-Ho Chow2, Nathaniel Rothman2, Amélie Chabrier1, Valérie Gaborieau1, Nic Timpson12, Rayjean J Hung1,13 and George Davey Smith12

1 International Agency for Research on Cancer (IARC), Genetic Epidemiology Group, Lyon, France.
2 National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
3 Cancer Research Centre, Institute of Carcinogenesis, Moscow, Russia.
4 Institute of Occupational Medicine, Department of Epidemiology, Lodz, Poland.
5 Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Department of Cancer Epidemiology and Prevention, Warsaw, Poland.
6 National Institute of Environmental Health, Budapest, Hungary.
7 Specialized Institute of Hygiene and Epidemiology, Banska Bystrica, Slovakia.
8 Institute of Public Health, Bucharest, Romania.
9 Charles University, First Faculty of Medicine, Institute of Hygiene and Epidemiology, Prague 2, Czech Republic.
10 Mazaryk Memorial Cancer Institute, Department of Cancer Epidemiology and Genetics, Brno, Czech Republic.
11 Palacky University, Faculty of Medicine, Department of Preventive Medicine, Olomouc, Czech Republic.
12 MRC Centre for Causal Analyses in Translational Epidemiology (CAiTE), Department of Social Medicine, Canynge Hall, Bristol, UK.
13 Samuel Lunenfeld Research Institute, Cancer Care Ontario Research Chair, University of Toronto, ON, Canada.

* Corresponding author. Dr Paul Brennan, Genetic Epidemiology Group, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008 Lyon, France. E-mail: brennan{at}iarc.fr


   Abstract

Background Obesity is a risk factor for several cancers although appears to have an inverse association with cancers strongly related to tobacco. Studying obesity is difficult due to numerous biases and confounding.

Methods To avoid these biases we used a Mendelian randomization approach incorporating an analysis of variants in the FTO gene that are strongly associated with BMI levels among 7000 subjects from a study of lung, kidney and upper-aerodigestive cancer.

Results The FTO A allele which is linked with increased BMI was associated with a decreased risk of lung cancer (allelic odds ratio (OR) = 0.92, 95% confidence interval (CI) 0.84–1.00). It was also associated with a weak increased risk of kidney cancer, which was more apparent before the age of 50 (OR = 1.44, CI 1.09–1.90).

Conclusion Our results highlight the potential for genetic variation to act as an unconfounded marker of environmentally modifiable factors, and offer the potential to obtain estimates of the causal effect of obesity. However, far larger sample sizes than studied here will be required to undertake this with precision.


Keywords Obesity, cancer, Mendelian randomization

Accepted 18 February 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
T. M Frayling
Commentary: A new dawn for genetic epidemiology?
Int. J. Epidemiol., August 1, 2009; 38(4): 975 - 977.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
S. Ebrahim
Ideology with evidence: global warming, maps and ethics
Int. J. Epidemiol., August 1, 2009; 38(4): 895 - 896.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.